XML 27 R17.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
SCHEDULE OF WARRANT ACTIVITY

A summary of the Company’s warrant activity and related information follows:

 

           Weighted 
       Weighted   Average 
       Average   Remaining 
   Number of   Exercise   Life 
   Warrants   Price   In Years 
Outstanding, January 1, 2025   3,951,634   $5.22      
Expired   (250)   60.00      
Outstanding, September 30, 2025   3,951,384   $5.21    2.55 
                
Exercisable, September 30, 2025   3,951,384   $5.21    2.55 
SCHEDULE OF STOCK OPTION GRANTED ASSUMPTIONS

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following assumptions:

 

   For the Nine Months Ended 
   September 30, 
   2025   2024 
Risk free interest rate   4.03 - 4.40%    4.14 - 4.30% 
Expected term (years)   2.77 - 5.38    2.77 - 5.38 
Expected volatility   98.14 - 99.22%    101 - 102% 
Expected dividends   0.00%   0.00%
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the stock option activity during the nine months ended September 30, 2025 is presented below:

 

           Weighted     
       Weighted   Average     
       Average   Remaining     
   Number of   Exercise   Life   Intrinsic 
   Options   Price   In Years   Value 
Outstanding, January 1, 2025   3,263,467   $2.63           
Granted   2,177,908    2.45           
Exercised   (29,249)   1.45           
Forfeited   (149,153)   2.23                
Outstanding, September 30, 2025   5,262,973   $2.58    7.8   $- 
                     
Exercisable, September 30, 2025   3,805,964   $2.72    7.3   $- 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table presents information related to stock-based compensation expense:

 

   2025   2024   2025   2024   2025   (Years) 
   For the Three Months Ended   For the Nine Months Ended   Unrecognized at   Weighted Average Remaining Amortization 
   September 30,   September 30,   September 30,   Period 
   2025   2024   2025   2024   2025   (Years) 
Research and development  $175,398   $133,333   $1,308,322   $1,314,298           
General and administrative  $224,535   $150,912   $1,569,444   $1,322,643           
Total  $399,932   $284,245   $2,877,766   $2,636,941   $1,878,612   1.76 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE BY AWARD TYPE

The following table presents stock-based compensation by award type:

 

   2025   2024   2025   2024 
   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2025   2024   2025   2024 
Options  $399,932   $284,245   $2,877,766   $1,651,903 
RSUs   -    -    -    985,038 
Total  $399,932   $284,245   $2,877,766   $2,636,941